Evogliptin ((R)-4-((R)-3-amino-4-(2,4,5-trifluorophenyl)butanoyl)-3-(tert-butoxymethyl) piperazine-2-one)) is a highly potent selective inhibitor of dipeptidyl peptidase IV (DPP4) that was approved for the treatment of type 2 diabetes in South Korea. In this study, we report the crystal structures of Evogliptin, DA-12166, and DA-12228 (S,R diastereomer of Evogliptin) complexed to human DPP4. Analysis of both the structures and inhibitory activities suggests that the binding of the trifluorophenyl moiety in the S1 pocket and the piperazine-2-one moiety have hydrophobic interactions with Phe357 in the S2 extensive subsite, and that the multiple hydrogen bonds made by the (R)-β-amine group in the S2 pocket and the contacts made by the (R)-tert-butyl group with Arg125 contribute to the high potency observed for Evogliptin.

Generating artificial protein assemblies with complex shapes requires a method for connecting protein components with stable and predictable structures. Currently available methods for creating rigid protein assemblies rely on either complicated calculations or extensive trial and error. We describe a simple and efficient method for connecting two proteins via a fused alpha helix that is formed by joining two preexisting helices into a single extended helix. Because the end-to-end ligation of helices does not guarantee the formation of a continuous helix, we superimposed 1–2 turns of pairs of connecting helices by using a molecular graphics program. Then, we chose amino acids from the two natural sequences that would stabilize the connecting helix. This “shared helix method” is highly efficient. All the designed proteins that could be produced in Escherichia coli were readily crystallized and had the expected fusion structures. To prove the usefulness of this method, we produced two novel repeat proteins by assembling several copies of natural or artificial proteins with alpha helices at both termini. Their crystal structures demonstrated the successful assembly of the repeating units with the intended curved shapes. We propose that this method could dramatically expand the available repertoire of natural repeat proteins.

The sodium-dependent citrate transporter of Klebsiella pneumoniae (KpCitS) belongs to the 2-hydroxycarboxylate transporter (2-HCT) family and allows the cell to use citrate as sole carbon and energy source in anaerobic conditions. Here we present crystal structures of KpCitS in citrate-bound outward-facing, citrate-bound asymmetric, and citrate-free inward-facing state. The structures reveal that the KpCitS dimerization domain remains stationary throughout the transport cycle due to a hydrogen bond network as well as extensive hydrophobic interactions. In contrast, its transport domain undergoes a ~35° rigid-body rotation and a ~17 Å translocation perpendicular to the membrane to expose the substrate-binding site alternately to either side of the membrane. Furthermore, homology models of two other 2-HCT proteins based on the KpCitS structure offer structural insights into their differences in substrate specificity at a molecular level. On the basis of our results and previous biochemical data, we propose that the activity of the 2-HCT CitS involves an elevator-like movement in which the transport domain itself traverses the lipid bilayer, carrying the substrate into the cell in a sodium-dependent manner.

The leukocyte common antigen-related receptor protein tyrosine phosphatases (LAR-RPTPs) are cellular receptors of heparan sulfate (HS) and chondroitin sulfate (CS) proteoglycans that direct axonal growth and neuronal regeneration. LAR-RPTPs are also synaptic adhesion molecules that form trans-synaptic adhesion complexes by binding to various postsynaptic adhesion ligands, such as Slit- and Trk-like family of proteins (Slitrks), IL-1 receptor accessory protein-like 1 (IL1RAPL1), interleukin-1 receptor accessory protein (IL-1RAcP) and neurotrophin receptor tyrosine kinase C (TrkC), to regulate synaptogenesis. Here, we determined the crystal structure of the human LAR-RPTP/IL1RAPL1 complex and found that lateral interactions between neighboring LAR-RPTP/IL1RAPL1 complexes in crystal lattices are critical for the higher-order assembly and synaptogenic activity of these complexes. Moreover, we found that LAR-RPTP binding to the postsynaptic adhesion ligands, Slitrk3, IL1RAPL1 and IL-1RAcP, but not TrkC, induces reciprocal higher-order clustering of trans-synaptic adhesion complexes. Although LAR-RPTP clustering was induced by either HS or postsynaptic adhesion ligands, the dominant binding of HS to the LAR-RPTP was capable of dismantling pre-established LAR-RPTP-mediated trans-synaptic adhesion complexes. These findings collectively suggest that LAR-RPTP clustering for synaptogenesis is modulated by a complex synapse-organizing protein network.

Lipopolysaccharide (LPS), the major component of the outer membrane of Gram-negative bacteria, binds Toll-like receptor 4 (TLR4)-MD2 complex and activates innate immune responses. LPS transfer to TLR4-MD2 is catalyzed by both LPS binding protein (LBP) and CD14. To define the sequential molecular interactions underlying this transfer, we reconstituted in vitro the entire LPS transfer process from LPS micelles to TLR4-MD2. Using electron microscopy and single-molecule approaches, we characterized the dynamic intermediate complexes for LPS transfer: LBP-LPS micelles, CD14-LBP-LPS micelle, and CD14-LPS-TLR4-MD2 complex. A single LBP molecule bound longitudinally to LPS micelles catalyzed multi-rounds of LPS transfer to CD14s that rapidly dissociated from LPB-LPS complex upon LPS transfer via electrostatic interactions. Subsequently, the single LPS molecule bound to CD14 was transferred to TLR4-MD2 in a TLR4- dependent manner. The definition of the structural determinants of the LPS transfer cascade to TLR4 may enable the development of targeted therapeutics for intervention in LPS-induced sepsis.

Building a sophisticated protein nano-assembly requires a method for linking protein components in a predictable and stable structure. Most of the cross linkers available have flexible spacers. Because of this, the linked hybrids have significant structural flexibility and the relative structure between their two components is largely unpredictable. Here we describe a method of connecting two proteins via a ‘fusion α helix' formed by joining two pre-existing helices into a single extended helix. Because simple ligation of two helices does not guarantee the formation of a continuous helix, we used EY-CBS, a synthetic cross linker that has been shown to react selectively with cysteines in α-helices, to stabilize the connecting helix. Formation and stabilization of the fusion helix was confirmed by determining the crystal structures of the fusion proteins with and without bound EY-CBS. Our method should be widely applicable for linking protein building blocks to generate predictable structures.

Building a sophisticated protein nano-assembly requires a method for linking protein components in a predictable and stable structure. Diabodies are engineered antibody fragments that are composed of two Fv domains connected by short peptide linkers. They are attractive candidates for mediators in assembling protein nano-structures because they can simultaneously bind to two different proteins and are rigid enough to be crystallized. However, comparison of previous crystal structures demonstrates that there is substantial structural diversity in the Fv interface region of diabodies and, therefore, reliable prediction of its structure is not trivial. Here, we present the crystal structures of ten mono- and bi-specific diabodies. We found that changing an arginine residue in the Fv interface to threonine greatly reduced the structural diversity of diabodies. We also found that one of the bispecific diabodies underwent an unexpected process of chain swapping yielding a non-functional monospecific diabody. In order to further reduce structural flexibility and prevent chain shuffling, we introduced disulfide bridges in the Fv interface regions. The disulfide-bridged diabodies have rigid and predictable structures and may have applications in crystallizing proteins, analyzing cryo-electron microscopic images and building protein nano-assemblies.

50. Kim, H., Youn, S.-J., Kim, S. O., Ko, J., Lee, J.-O. & Choi, B.-S. Structural Studies of Potassium Transport Protein KtrA Regulator of Conductance of K+(RCK) C Domain in Complex with Cyclic Diadenosine Monophosphate (c-di-AMP). Journal of Biological Chemistry290, 16393–16402 (2015). 49. Hwang, J., Suh, H.-W., Jeon, Y. H., Hwang, E., Nguyen, L. T., Yeom, J., Lee, S.-G., Lee, C., Kim, K. J., Kang, B. S., Jeong, J.-O., Oh, T.-K., Choi, I., Lee, J.-O. & Kim, M. H. The structural basis for the negative regulation of thioredoxin by thioredoxin-interacting protein. Nature Communications 5, (2014). 48. Um, J. W., Kim, K. H., Park, B. S., Choi, Y., Kim, D., Kim, C. Y., Kim, S. J., Kim, M., Ko, J. S., Lee, S.-G., Choii, G., Nam, J., Heo, W. D., Kim, E., Lee, J.-O., Ko, J. & Kim, H. M. Structural basis for LAR-RPTP/Slitrk complex-mediated synaptic adhesion. Nature Communications 5,(2014). 47. Eckert, J. K., Kim, Y. J., Kim, J. I., Gürtler, K., Oh, D.-Y., Sur, S., Lundvall, L., Hamann, L., van der Ploeg, A., Pickkers, P., Giamarellos-Bourboulis, E., Kubarenko, A. V., Weber, A. N., Kabesch, M., Kumpf, O., An, H.-J., Lee, J.-O. & Schumann, R. R. The Crystal Structure of Lipopolysaccharide Binding Protein Reveals the Location of a Frequent Mutation that Impairs Innate Immunity. Immunity 39, 647–660 (2013). 46. An, H.-J., Cho, G., Lee, J.-O., Paik, S.-G., Kim, Y. S. & Lee, H. Higd-1a interacts with Opa1 and is required for the morphological and functional integrity of mitochondria. Proceedings of the National Academy of Sciences 110, 13014–13019 (2013). 45. Liu, D., Ryu, K.-S., Ko, J., Sun, D., Lim, K., Lee, J.-O., Hwang, J. m., Lee, Z. -w. & Choi, B.-S. Insights into the regulation of human Rev1 for translesion synthesis polymerases revealed by the structural studies on its polymerase-interacting domain. Journal of Molecular Cell Biology 5, 204–206 (2012). 44. Park, B. S. & Lee, J.-O. Recognition of lipopolysaccharide pattern by TLR4 complexes. Experimental & Molecular Medicine 45, e66–e66 (2013). 43. Hwang, J., Kim, B. S., Jang, S. Y., Lim, J. G., You, D.-J., Jung, H. S., Oh, T.-K., Lee, J.-O., Choi, S. H. & Kim, M. H. Structural insights into the regulation of sialic acid catabolism by the Vibrio vulnificus transcriptional repressor NanR. Proceedings of the National Academy of Sciences 110, E2829–E2837 (2013). 42. Song, D. H. & Lee, J.-O. Sensing of microbial molecular patterns by Toll-like receptors. Immunological Reviews 250, 216–229 (2012). 41. Kim, S. O., Yoon, H., Park, S. O., Lee, M., Shin, J.-S., Ryu, K.-S., Lee, J.-O., Seo, Y.-S., Jung, H. S. & Choi, B.-S. Srs2 possesses a non-canonical PIP box in front of its SBM for precise recognition of SUMOylated PCNA. Journal of Molecular Cell Biology 4, 258–261 (2012). 40. An, H.-J., Shin, H., Jo, S.-G., Kim, Y. J., Lee, J.-O., Paik, S.-G. & Lee, H. The survival effect of mitochondrial Higd-1a is associated with suppression of cytochrome C release and prevention of caspase activation. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1813, 2088–2098 (2011). 39. Kang, J. Y. & Lee, J.-O. Structural Biology of the Toll-Like Receptor Family. Annual Review of Biochemistry 80, 917–941 (2011). 38. Hwang, J., Kim, Y., Kang, H. B., Jaroszewski, L., Deacon, A. M., Lee, H., Choi, W.-C., Kim, K.-J., Kim, C.-H., Kang, B. S., Lee, J.-O., Oh, T.-K., Kim, J. W., Wilson, I. A. & Kim, M. H. Crystal Structure of the Human N-Myc Downstream-regulated Gene 2 Protein Provides Insight into Its Role as a Tumor Suppressor. Journal of Biological Chemistry 286, 12450–12460 (2011). 37. An, H.-J., Kim, Y. J., Song, D. H., Park, B. S., Kim, H. M., Lee, J. D., Paik, S.-G., Lee, J.-O. & Lee, H. Crystallographic and Mutational Analysis of the CD40-CD154 Complex and Its Implications for Receptor Activation. Journal of Biological Chemistry 286, 11226–11235 (2011). 36. Park, W. S., Kang, S. K., Jun, M. A., Shin, M. S., Kim, K. Y., Rhee, S. D., Bae, M. A., Kim, M. S., Kim, K. R., Kang, N. S., Yoo, S., Lee, J. O., Song, D. H., Silinski, P., Schneider, S. E., Ahn, J. H. & Kim, S. S. Discovery of β-aminoacyl containing thiazolidine derivatives as potent and selective dipeptidyl peptidase IV inhibitors. Bioorganic & Medicinal Chemistry Letters 21, 1366–1370 (2011). 35. Ko, J., Ryu, K.-S., Kim, H., Shin, J.-S., Lee, J.-O., Cheong, C. & Choi, B.-S. Structure of PP4397 Reveals the Molecular Basis for Different c-di-GMP Binding Modes by Pilz Domain Proteins. Journal of Molecular Biology 398, 97–110 (2010). 34. Kang, J. Y., Nan, X., Jin, M. S., Youn, S.-J., Ryu, Y. H., Mah, S., Han, S. H., Lee, H., Paik, S.-G. & Lee, J.-O. Recognition of Lipopeptide Patterns by Toll-like Receptor 2-Toll-like Receptor 6 Heterodimer. Immunity 31, 873–884 (2009). 33. Ryu, K.-S., Lee, J.-O., Kwon, T. H., Choi, H.-H., Park, H.-S., Hwang, S. K., Lee, Z.-W., Lee, K.-B., Han, Y. H., Choi, Y.-S., Jeon, Y. H., Cheong, C. & Kim, S. The presence of monoglucosylated N196-glycan is important for the structural stability of storage protein, arylphorin. Biochemical Journal 421, 87–96 (2009). 32. Jung, K., Lee, J.-E., Kim, H.-Z., Kim, H. M., Park, B. S., Hwang, S.-I., Lee, J.-O., Kim, S. C. & Koh, G. Y. Toll-Like Receptor 4 Decoy, TOY, Attenuates Gram-Negative Bacterial Sepsis. PLoS ONE 4, e7403 (2009). 31. Park, B. S., Song, D. H., Kim, H. M., Choi, B.-S., Lee, H. & Lee, J.-O. The structural basis of lipopolysaccharide recognition by the TLR4–MD-2 complex. Nature 458, 1191–1195 (2009). 30. Jin, M. S. & Lee, J. Ligand recognition by the toll‐like receptor family. Animal Cells and Systems 13, 1–8 (2009). 29. Ahn, J. H., Park, W. S., Jun, M. A., Shin, M. S., Kang, S. K., Kim, K. Y., Rhee, S. D., Bae, M. A., Kim, K. R., Kim, S. G., Kim, S. Y., Sohn, S. K., Kang, N. S., Lee, J. O., Lee, D. H., Cheon, H. G. & Kim, S. S. Synthesis and biological evaluation of homopiperazine derivatives with β-aminoacyl group as dipeptidyl peptidase IV inhibitors. Bioorganic & Medicinal Chemistry Letters 18, 6525–6529 (2008). 28. Jun, M. A., Park, W. S., Kang, S. K., Kim, K. Y., Kim, K. R., Rhee, S. D., Bae, M. A., Kang, N. S., Sohn, S.-K. & Kim, S. G. Synthesis and biological evaluation of pyrazoline analogues with β-amino acyl group as dipeptidyl peptidase IV inhibitors. European Journal of Medicinal Chemistry 43, 1889–1902 (2008). 27. Jin, M. S. & Lee, J.-O. Structures of TLR–ligand complexes. Current Opinion in Immunology 20, 414–419 (2008). 26. Jin, M. S. & Lee, J.-O. Structures of the Toll-like Receptor Family and Its Ligand Complexes. Immunity 29, 182–191 (2008). 25. Lee, K. E., Kim, H. M., Lee, J.-O., Jeon, H. & Han, S. S. Regulation of CD40 reconstitution into a liposome using different ratios of solubilized LDAO to lipids. Colloids and Surfaces B: Biointerfaces 62, 51–57 (2008). 24. Jin, M. S., Kim, S. E., Heo, J. Y., Lee, M. E., Kim, H. M., Paik, S.-G., Lee, H. & Lee, J.-O. Crystal Structure of the TLR1-TLR2 Heterodimer Induced by Binding of a Tri-Acylated Lipopeptide. Cell 130, 1071–1082 (2007). 23. Hwang, E., Ryu, K.-S., Paakkonen, K., Guntert, P., Cheong, H.-K., Lim, D.-S., Lee, J.-O., Jeon, Y. H. & Cheong, C. Structural insight into dimeric interaction of the SARAH domains from Mst1 and RASSF family proteins in the apoptosis pathway. Proceedings of the National Academy of Sciences 104, 9236–9241 (2007). 22. Kim, H. M., Park, B. S., Kim, J.-I., Kim, S. E., Lee, J., Oh, S. C., Enkhbayar, P., Matsushima, N., Lee, H., Yoo, O. J. & Lee, J.-O. Crystal Structure of the TLR4-MD-2 Complex with Bound Endotoxin Antagonist Eritoran. Cell 130, 906–917 (2007). 21. Yoon, M.-K., Kim, H.-M., Choi, G., Lee, J.-O. & Choi, B.-S. Structural Basis for the Conformational Integrity of theArabidopsis thalianaHY5 Leucine Zipper Homodimer. Journal of Biological Chemistry 282, 12989–13002 (2007). 20. Ahn, J. H., Shin, M. S., Jun, M. A., Jung, S. H., Kang, S. K., Kim, K. R., Rhee, S. D., Kang, N. S., Kim, S. Y., Sohn, S.-K., Kim, S. G., Jin, M. S., Lee, J. O., Cheon, H. G. & Kim, S. S. Synthesis, biological evaluation and structural determination of β-aminoacyl-containing cyclic hydrazine derivatives as dipeptidyl peptidase IV (DPP-IV) inhibitors. Bioorganic & Medicinal Chemistry Letters 17, 2622–2628 (2007). 19. Kim, H. M., Oh, S. C., Lim, K. J., Kasamatsu, J., Heo, J. Y., Park, B. S., Lee, H., Yoo, O. J., Kasahara, M. & Lee, J.-O. Structural Diversity of the Hagfish Variable Lymphocyte Receptors. Journal of Biological Chemistry 282, 6726–6732 (2006). 18. An, H.-J., Maeng, O., Kang, K.-H., Lee, J.-O., Kim, Y.-S., Paik, S.-G. & Lee, H. Activation of Ras Up-regulates Pro-apoptotic BNIP3 in Nitric Oxide-induced Cell Death. Journal of Biological Chemistry 281, 33939–33948 (2006). 17. Oh, H. J., Lee, K.-K., Song, S. J., Jin, M. S., Song, M. S., Lee, J. H., Im, C. R., Lee, J.-O., Yonehara, S. & Lim, D.-S. Role of the Tumor Suppressor RASSF1A in Mst1-Mediated Apoptosis. Cancer Research 66, 2562–2569 (2006). 16. An, S., Cho, K.-H., Lee, W. S., Lee, J.-O., Paik, Y.-K. & Jeong, T.-S. A critical role for the histidine residues in the catalytic function of acyl-CoA:cholesterol acyltransferase catalysis: Evidence for catalytic difference between ACAT1 and ACAT2. FEBS Letters 580, 2741–2749 (2006). 15. Ryu, K.-S., Kim, J.-I., Cho, S.-J., Park, D., Park, C., Cheong, H.-K., Lee, J.-O. & Choi, B.-S. Structural Insights into the Monosaccharide Specificity of Escherichia coli Rhamnose Mutarotase. Journal of Molecular Biology 349, 153–162 (2005). 14. Kim, J.-I., Lee, C. J., Jin, M. S., Lee, C.-H., Paik, S.-G., Lee, H. & Lee, J.-O. Crystal Structure of CD14 and Its Implications for Lipopolysaccharide Signaling. Journal of Biological Chemistry 280, 11347–11351 (2005). 13. Yook, Y.-H., Kang, K.-H., Maeng, O., Kim, T.-R., Lee, J.-O., Kang, K., Kim, Y. S., Paik, S.-G. & Lee, H. Nitric oxide induces BNIP3 expression that causes cell death in macrophages. Biochemical and Biophysical Research Communications 321, 298–305 (2004). 12. Maeng, O., Kim, Y. C., Shin, H.-J., Lee, J.-O., Huh, T.-L., Kang, K., Kim, Y. S., Paik, S.-G. & Lee, H. Cytosolic NADP+-dependent isocitrate dehydrogenase protects macrophages from LPS-induced nitric oxide and reactive oxygen species. Biochemical and Biophysical Research Communications 317, 558–564 (2004). 11. Zhukovsky, E. A., Lee, J.-O., Villegas, M., Chan, C., Chu, S. & Mroske, C. Is TALL-1 a trimer or a virus-like cluster? Nature 427, 413–414 (2004). 10. Sung, B.-J., Yeon Hwang, K., Ho Jeon, Y., Lee, J. I., Heo, Y.-S., Hwan Kim, J., Moon, J., Min Yoon, J., Hyun, Y.-L., Kim, E., Jin Eum, S., Park, S.-Y., Lee, J.-O., Gyu Lee, T., Ro, S. & Myung Cho, J. Structure of the catalytic domain of human phosphodiesterase 5 with bound drug molecules. Nature 425, 98–102 (2003). 9. Kim, H. M., Shin, D. R., Yoo, O. J., Lee, H. & Lee, J.-O. Crystal structure of Drosophila angiotensin I-converting enzyme bound to captopril and lisinopril1. FEBS Letters 538, 65–70 (2003). 8. Kim, H. M., Yu, K. S., Lee, M. E., Shin, D. R., Kim, Y. S., Paik, S.-G., Yoo, O. J., Lee, H. & Lee, J.-O. Crystal structure of the BAFF–BAFF-R complex and its implications for receptor activation. Nature Structural & Molecular Biology 10, 342–348 (2003). 7. Lee, M. E., Markowitz, J., Lee, J.-O. & Lee, H. Crystal structure of phosphodiesterase 4D and inhibitor complex1. FEBS Letters 530,53–58 (2002). 6. Lee, J.-O., Yang, H., Georgescu, M.-M., Di Cristofano, A., Maehama, T., Shi, Y., Dixon, J. E., Pandolfi, P. & Pavletich, N. P. Crystal Structure of the PTEN Tumor Suppressor. Cell 99, 323–334 (1999). 5. Bardwell, J. C., Lee, J. O., Jander, G., Martin, N., Belin, D. & Beckwith, J. A pathway for disulfide bond formation in vivo. Proceedings of the National Academy of Sciences 90, 1038–1042 (1993). 4. Russo, A. A., Tong, L., Lee, J.-O., Jeffrey, P. D. & Pavletich, N. P. Structural basis for inhibition of the cyclin-dependent kinase Cdk6 by the tumour suppressor p16INK4a. Nature 395, 237–243 (1998). 3. Lee, J.-O., Russo, A. A. & Pavletich, N. P. Structure of the retinoblastoma tumour-suppressor pocket domain bound to a peptide from HPV E7. Nature 391, 859–865 (1998). 2. Lee, J.-O., Rieu, P., Arnaout, M. A. & Liddington, R. Crystal structure of the A domain from the a subunit of integrin CR3 (CD11 b/CD18). Cell 80, 631–638 (1995). 1. Lee, J.-O., Bankston, L. A. & Robert C Liddington, M. A. A. and. Two conformations of the integrin A-domain (I-domain): a pathway for activation Structure 3, 1333–1340 (1995).